LTGO

13.0301.59%
TN

Todd N. Smith

PresIdent, CEO & Director

Mr. Todd N. Smith was Independent Director of Latigo Biotherapeutics, Inc. from May 2026 until November 03, 2026 and serves as its President, CEO and Director since November 03, 2026. He has more than three decades of executive leadership and commercial experience across the biotechnology and pharmaceutical industries. He serves as Chief Executive Officer at Corium, LLC since 2025. He served as CEO of Iroko Pharmaceuticals and Assertio Therapeutics. He served as chief commercial officer (CCO) and head of business development at Horizon Therapeutics and CCO at Tolmar Pharmaceuticals, following commercial leadership roles at Abbott Labs. He serves on the boards of BVI Medica He serves as Operating Partner at NewVale Capital LLC. He is Founder of Apollo Care. He serves as Senior Advisor at Athyrium Capital Management, LP, where he focuses on Private Debt. He serves as Director at Quetzal Therapeutics, LLC since November 2025. He serves as Director at BVI Group Limited since August 20, 2021. He serves as Director at Beaver-Visitec International, Inc. He serves as Independent Director at Vault Nano Inc. He served as Chief Executive Officer, President and Director at Assertio Holdings, Inc. from May 19, 2020 to December 14, 2020. He served as President, Chief Executive Officer and Director at Zyla Life Sciences since October 22, 2019. He served as Chief Executive Officer of Valinor Pharma. He served as Chief Commercial Officer and Senior Vice President at IVERIC bio, Inc. from October 3, 2014 to August 31, 2015. He served as Chief Commercial Officer and Executive Vice President of Horizon Therapeutics Public Limited Company since February 2012. At Horizon Therapeutics Public Limited Company, he also served as Senior Vice President of Sales, Marketing & Business Development from October 1, 2010 to June 2012. He joined the firm on October 1, 2010. From January 2009 to August 2010, Mr. Smith served as Vice President, global marketing and strategy and business development at Fenwal Inc. and managed a team located in the U.S. and abroad. At Fenwal Inc., he also served as Vice President of Automated Business from May 2008 to January 2009 and as Amicus Category Business Unit Director from November 2007 to May 2008. From April 2006 to November 2007, he served as Director of Marketing, Virology Franchise at Abbott Laboratories and managed marketing and field teams. From March 2004 to April 2006, he served as Director of Sales -Virology Franchise at Abbott Laboratories managing a sales and training team. He served as Deputy Director, Product Management, Segment Markets and Managed Care at Bayer Biological Products from April 2003 to April 2004. At Bayer Biological Products, he also served as Associate Director of Coagulation Products from April 2002 to April 2003. From April 2001 to April 2002, he served as Associate Director of Business Development at Achillion Pharmaceuticals, Inc. Prior to April 2001, he served as a Regional Sales Manager, Product Manager and Sales Specialist at Agouron Pharmaceuticals, Inc. Mr. Smith is a seasoned commercial leader with several years' experience in the biopharmaceutical, pharmaceutical and biotechnology industry, holding a succession of senior management roles in sales, marketing and business development. He has sales and marketing experience and a record of achieving commercial excellence. He has led or participated in several product launches and product portfolios. He has built high-performing commercial and marketing teams. He earned a B.A. in Political Science from Norwich University.

Positions